Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

CoreAge Rx vs Eve

Two GLP-1 providers, one scoreboard. We put CoreAge Rx and Eve head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 1 · Grade A

CoreAge Rx

Visit CoreAge Rx Full brief →
vs
No. 372 · Grade C

Eve

Visit Eve Full brief →

The verdict

CoreAge Rx takes this head-to-head.

CoreAge Rx scores 94 to 59 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.

That doesn't make Eve a bad call — it's best for readers who can confirm a complete quote and the subscription terms before agreeing to treatment. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
97
48
Supply Reliability
95
71
Transparency
90
32
Access Breadth
93
62
Clinical Oversight
92
79
Track Record
88
73
CoreAge RxBrief Score 94 · 59Eve

Price, coverage & the tracker

CoreAge RxEve
Brief Score94/100 (A)59/100 (C)
Semaglutide

From $79/mo

Annual offer: 12 months paid upfront, from $948.

Main site: from $99/mo; confirm the selected offer.

Full price details

From $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo

Brand names are listed. Price and stock for your prescription are unconfirmed.

Tirzepatide

From $129/mo

Annual offer: 12 months paid upfront, from $1,548.

Main site: from $149/mo; confirm the selected offer.

Full price details

From $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo

A brand-name option is listed. Price and stock for your prescription are unconfirmed.

CoverageUS only; restrictions by state, confirmed at intakeConfirm a clinician and pharmacy can serve your location.
Brand-name accessNot confirmedYes
Oral / sublingualInjection onlyYes
On the trackerStableprice stableNewnew to the tracker, no prior reading

CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.

Eve: Confirm the exact drug, pharmacy and renewal charge after evaluation.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.